Determination of HCC With Octanoate Breath Test vs. MRI Diagnosis

NCT02794805 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 74

Last updated 2022-12-20

No results posted yet for this study

Summary

An Octanoate breath test will be used to assess the presence of Hepatocellular Carcinoma in subjects with risk. The gold standard will be MRI.

Conditions

  • Hepatocellular Carcinoma (HCC)

Interventions

DEVICE

¹³C-Octanoate Breath Test

Octanoate Breath Test to be performed on subjects with suspected HCC

Sponsors & Collaborators

  • Meridian Bioscience, Inc.

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2017-03-31
Completion
2017-04-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02794805 on ClinicalTrials.gov